Calton & Associates’s CME Group CME Stock Holding History

Calton & Associates’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-797	Closed	-$235K	–	430
2026 Q1	$235K	Buy	+797	New	+$237K	0.03%	385
2019 Q1	–	Sell	-1,700	Closed	-$320K	–	264
2018 Q4	$320K	Buy	+1,700	New	+$314K	0.12%	161
2018 Q2	–	Sell	-6,910	Closed	-$1.12M	–	311
2018 Q1	$1.12M	Hold	6,910	–	–	0.32%	60
2017 Q4	$1.06M	Buy	+6,910	New	+$984K	0.27%	65

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Calton & Associates's CME Position: Q2 2026 in Review

Calton & Associates sold out of CME Group (CME) in Q2 2026, closing a stake of 797 shares — an estimated $235K sold.

Calton & Associates first reported a position in CME in Q4 2017 and held it in 4 quarters. The position peaked at $1.12M in Q1 2018. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Calton & Associates reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
Calton & Associates sold 797 CME Group shares in Q2 2026, an estimated $235K.
Calton & Associates first reported a position in CME Group in Q4 2017 and held it in 4 quarters.
Calton & Associates's CME Group position peaked at $1.12M in Q1 2018.
1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Calton & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.